FMFederico Maisano

Federico Maisano

*This is an algorithmically generated author record based on publicly available information.

Federico Maisano has a total of 54 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Solution Structures and Dynamics of Diamagnetic Lu– and Y–DOTAM/Fluoride Ternary Complexes: The Role of 19 F-CEST in the Detection of the Complex Fluoride Speciation

    by Francesca Garello, Diana Costanzo, Carla Carrera, Giuseppe Digilio, Gianluca Destro, Francesco Blasi, Federico Maisano, Silvio Aime, Enzo Terreno

    This study deals with the synthesis and 1H, 13C, and 19F-NMR characterization of ternary complexes formed upon the addition of fluoride ions to Lu- and Y-DOTAM. The application of the 19F-CEST protocols allowed to get more insight into the complex speciation of the products of this reaction. In fact, the enhanced sensitivity associated with this technique revealed the presence of other fluoride-containing complexes beyond the main product represented by the simple replacement of the coordinated water molecule in the axial position of the square antiprismatic geometry usually adopted when the macrocycle DOTAM ligand wraps around a metal ion. Both Lu(III) and Y(III) yielded low amounts of a derivative containing a fluoride anion bridging two DOTAM complexes. In the case of the larger Y(III) ion, an additional species was detected, likely due to the expansion to ten of its coordination number. The exchange of the coordinated fluoride with the free anion has also been investigated by 2D-19F-EXSY and selective inversion-recovery experiments, thus yielding additional routes to assess the lifetime of the fluoride anion at its coordination site.

  • Open Access

    Comment on Somnin et al. Study of Interactions Between Gadolinium-Based Contrast Agents and Collagen by Taylor Dispersion Analysis and Frontal Analysis Continuous Capillary Electrophoresis. Pharmaceuticals 2024, 17, 1633

    by Nicol Guidolin, Federico Maisano, Fabio Tedoldi, Zsolt Baranyai

    With great interest, we read the recent paper published in Pharmaceuticals, titled “Study of Interactions Between Gadolinium-Based Contrast Agents and Collagen by Taylor Dispersion Analysis and Frontal Analysis Continuous Capillary Electrophoresis”


  • Open Access

    Improved synthesis of DA364, an NIR fluorescence RGD probe targeting αvβ3 integrin

    by Rachele Maschio, Federica Buonsanti, Federico Crivellin, Fulvio Ferretti, Luciano Lattuada, Federico Maisano, Laura Orio, Lorena Pizzuto, Raphael Campanella, Anthony Clouet, et al.

    Significant improvements in the synthetic approach to the αvβ3-targeted NIR-fluorescent probe DA364 are reported.

  • Open Access

    Gadolinium Clearance in the First 5 Weeks After Repeated Intravenous Administration of Gadoteridol, Gadoterate Meglumine, and Gadobutrol to rats

    by Simona Bussi, Alessandra Coppo, Roberta Bonafè, Silvia Rossi, Sonia Colombo Serra, Laure Penard, Miles A. Kirchin, Federico Maisano, Fabio Tedoldi

    Background: Studies of gadolinium (Gd) clearance from animals in the first weeks after administration of gadolinium‐based contrast agents (GBCAs) have previously looked at solitary timepoints only. However, this does not give information on differences between GBCAs and between organs in terms of Gd elimination kinetics.Purpose: To compare Gd levels in rat cerebellum, cerebrum, skin, and blood at 1, 2, 3, and 5 weeks after repeated administration of macrocyclic GBCAs.Study Type: Prospective.Animal Model: One hundred eighty male Sprague–Dawley rats randomized to three groups (n = 60/group), received intravenous administrations of gadoteridol, gadoterate meglumine, or gadobutrol (0.6 mmol/kg for each) four times/week for 5 consecutive weeks. Rats were sacrificed after washout periods of 1, 2, 3, or 5 weeks.Field Strength/Sequence: Not applicable.Assessment: Cerebellum, cerebrum, skin, and blood were harvested for Gd determination by inductively coupled plasma‐mass spectrometry (15 animals/group/all timepoints).Statistical Tests: Anova and Dunnett's test (data with homogeneous variances and normal distribution). Kruskal–Wallis and Wilcoxon's rank sum tests (data showing nonhomogeneous variances or a non‐normal distribution, significance levels: P < 0.05, P < 0.01, and P < 0.001).Results: Gd levels in cerebellum, cerebrum, and skin were significantly lower after gadoteridol than after gadoterate and gadobutrol at all timepoints. Mean cerebellum Gd concentrations after gadoteridol, gadoterate, and gadobutrol decreased from 0.693, 0.878, and 1.011 nmol Gd/g at 1 week to 0.144, 0.282, and 0.297 nmol Gd/g at 5 weeks after injection. Similar findings were noted for cerebrum and skin. Conversely, significantly higher Gd levels were noted in blood after gadoteridol compared to gadobutrol at 1, 2, and 3 weeks and compared to gadoterate at all timepoints.Data Conclusion: Gadoteridol is eliminated more rapidly from rat cerebellum, cerebrum, and skin compared to gadoterate and gadobutrol in the first 5 weeks after administration, resulting in lower levels of retained Gd in these tissues.Evidence Level: 1Technical Efficacy: Stage 5


  • Interaction of macrocyclic gadolinium-based MR contrast agents with Type I collagen. Equilibrium and kinetic studies

    by Nicol Guidolin, Fabio Travagin, Giovanni B. Giovenzana, Adrienn Vágner, Sophia Lotti, Federica Chianale, Ernő Brücher, Federico Maisano, Miles A. Kirchin, Fabio Tedoldi, et al.

    Collagen can form electrostatic interactions and hydrogen-bonds with macrocyclic GdIII-complexes which might explain their differentin vivoretention.


  • Open Access

    Non-clinical assessment of safety and gadolinium deposition after cumulative administration of gadobenate dimeglumine (MultiHance ® ) to neonatal and juvenile rats

    by Simona Bussi, Laure Penard, Roberta Bonafè, Catherine Botteron, Roberto Celeste, Alessandra Coppo, Roberta Queliti, Miles A. Kirchin, Fabio Tedoldi, Federico Maisano


  • Open Access

    Differences in gadolinium retention after repeated injections of macrocyclic MR contrast agents to rats

    by Simona Bussi, Alessandra Coppo, Catherine Botteron, Valérie Fraimbault, Antonello Fanizzi, Elisa De Laurentiis, Sonia Colombo Serra, Miles A. Kirchin, Fabio Tedoldi, Federico Maisano

    Purpose: To compare the levels of gadolinium in the blood, cerebrum, cerebellum, liver, femur, kidneys, and skin after multiple exposure of rats to the macrocyclic gadolinium‐based contrast agents (GBCAs) gadoterate, gadobutrol, and gadoteridol.Materials and Methods: Fifty male Wistar Han rats were randomized to three exposure groups (n = 15 per group) and one control group (n = 5). Animals in the exposure groups received a total of 20 GBCA administrations (four administrations per week for 5 consecutive weeks) at a dose of 0.6 mmol/kg bodyweight. After a 28‐day recovery period animals were sacrificed and the blood and tissues harvested for determination of gadolinium (Gd) levels. Gd determination was performed by inductively coupled plasma mass spectrometry (ICP‐MS).Results: After 28 days' recovery no Gd was found in the blood, liver, or skin of any animal in any group. Significantly lower levels of Gd were noted with gadoteridol compared to gadoterate and gadobutrol in the cerebellum (0.150 ± 0.022 vs. 0.292 ± 0.057 and 0.287 ± 0.056 nmol/g, respectively; P < 0.001), cerebrum (0.116 ± 0.036 vs. 0.250 ± 0.032 and 0.263 ± 0.045 nmol/g, respectively; P < 0.001), and kidneys (25 ± 13 vs. 139 ± 88 [P < 0.01] and 204 ± 109 [P < 0.001], respectively). Higher levels of Gd were noted in the femur (7.48 ± 1.37 vs. 5.69 ± 1.75 and 8.60 ± 2.04 nmol/g, respectively) with significantly less Gd determined for gadoterate than for gadobutrol (P < 0.001) and gadoteridol (P < 0.05).Conclusion: Differences exist between macrocyclic agents in terms of their propensity to accumulate in tissues. The observed differences in Gd concentration point to differences in GBCA washout rates in this setting and in this experimental model, with gadoteridol being the GBCA that is most efficiently removed from both cerebral and renal tissues.Level of Evidence: 2Technical Efficacy: Stage 5J. Magn. Reson. Imaging 2018;47:746–752.


    • 1 April 2006
      • Vol. 17  (2) , 131-7

    Validation of a reversed-phase HPLC method for quantitative amino acid analysis.

    by Maria Paola Bartolomeo, Federico Maisano

    A semi-automated method for amino acid derivatization and analysis has been validated for use in analysis of protein biopharmaceuticals. The method includes protein hydrolysis, o-phthalaldehyde derivatization, and reversed-phase high-performance liquid chromatography analysis in a general-purpose UV-visible high-performance liquid chromatography system. Amino-acid derivatization is performed automatically by the high-performance liquid chromatography autosampler right before injection. The required validation parameters, i.e., specificity, linearity, accuracy, precision, limit of detection, and limit of quantification, were studied for bovine serum albumin and for a recombinant human Fab fragment. The method can be employed as an absolute quantification method for determination of extinction coefficients of recombinant proteins.


  • Open Access

    Assessment of a new synbiotic preparation in healthy volunteers: survival, persistence of probiotic strains and its effect on the indigenous flora

    by Lorenzo Morelli, Daniela Zonenschain, Maria Luisa Callegari, Enzo Grossi, Federico Maisano, Michele Fusillo

    Use of synbiotic preparations as dietary supplement is believed to be a valid approach to restore and maintain colonic microflora. However, only few papers have been published on the assessment of these food supplements and none of them have used molecular biology techniques to evaluate the effects of the probiotic components. Twelve healthy volunteers were recruited. Faecal samples were taken before and at various time points during the administration period and at day 3 in the post-treatment period. Stool culture were performed and amplified ribosomal DNA restriction analysis was used to detect L. paracasei, the major bacterial component of the synbiotic products. An increase of at least 1 log of L. paracasei-like bacteria was observed in all subjects. An increase of as much as 3 log was seen in subjects who had a low number of L. paracasei-like lactobacilli at the baseline. The counts of L. paracasei-like lactobacilli were found to persist for at least 3 days after discontinuation of intake in healthy volunteers in 7 subjects. Genetic analysis showed that the maiority of vancomicin insensitive lactobacilli were real L. paracasei, as the strains administered with the tested product. This study has shown that the strains of L paracasei administered with a synbiotic dietary supplement are able to survive through the gastrointestinal tract and to persist for at least a few days. It was also shown the efficacy of a synbiotic preparation to positively affect the microflora of healthy volunteers.